Incorporated in 2007, HeartSciences (formerly known as Heart Test Laboratories) is a privately held medical technology company located in the Dallas-Fort Worth metroplex, the largest economic area in the Southern United States. For a decade, HeartSciences has been dedicated to the development of accurate, affordable cardiac testing tools for the early detection of heart disease.
To date, HeartSciences has invested more than $30M in research and development in an effort to fundamentally improve the sensitivity of an electrocardiograph (ECG/EKG) for the early detection of heart disease. The ECG is a device that has not experienced significant clinical advancement in decades, until now.
MyoVista® High Sensitivity ECG (hsECG™) Cardiac Testing Device, the industry’s first electrocardiographic device that applies proprietary use of Continuous Wavelet Transform (CWT) signal processing technology represents the first product from the years of research and development.